Trials / Unknown
UnknownNCT05822661
Impact of Black Seed Oil on Hemodialysis Patients
Evaluation of the Impact of Black Seed Oil on Hemodialysis Patients
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Ain Shams University · Academic / Other
- Sex
- All
- Age
- 20 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to evaluate the effect of black seed oil on endothelial dysfunction, oxidative stress and quality of life in hemodialysis patients.
Detailed description
Evaluation of the effect of black seed oil in hemodialysis patients via: * Evaluation of serum Endothelin-1 levels * Evaluation of serum Malondialdehyde (MDA) levels * Evaluation of serum Total Antioxidant Capacity (TAC) levels * Evaluation of Quality of Life (QOL) * Evaluation of fatigue scale
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Black Seed Oil | Dietary supplement |
| DIETARY_SUPPLEMENT | Placebo | placebo capsules same odor, color and size as the drug but without the active ingredient |
Timeline
- Start date
- 2023-02-22
- Primary completion
- 2023-04-23
- Completion
- 2023-04-23
- First posted
- 2023-04-21
- Last updated
- 2023-04-21
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05822661. Inclusion in this directory is not an endorsement.